BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 38729941)

  • 1. The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review.
    Vakilpour A; Amini-Salehi E; Soltani Moghadam A; Keivanlou MH; Letafatkar N; Habibi A; Hashemi M; Eslami N; Zare R; Norouzi N; Delam H; Joukar F; Mansour-Ghanaei F; Hassanipour S; Samethadka Nayak S
    Nutr Diabetes; 2024 May; 14(1):25. PubMed ID: 38729941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis.
    Amini-Salehi E; Hassanipour S; Keivanlou MH; Shahdkar M; Orang Goorabzarmakhi M; Vakilpour A; Joukar F; Hashemi M; Sattari N; Javid M; Mansour-Ghanaei F
    Nutr Rev; 2024 May; 82(6):815-830. PubMed ID: 37550264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: An umbrella study on meta-analyses.
    Mahapatro A; Bawna F; Kumar V; Daryagasht AA; Gupta S; Raghuma N; Moghdam SS; Kolla A; Mahapatra SS; Sattari N; Amini-Salehi E; Nayak SS
    Clin Nutr ESPEN; 2023 Oct; 57():475-486. PubMed ID: 37739694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study.
    Naghipour A; Amini-Salehi E; Orang Gorabzarmakhi M; Shahdkar M; Fouladi B; Alipourfard I; Sanat ZM
    Syst Rev; 2023 Aug; 12(1):144. PubMed ID: 37605283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.
    Bock PM; Telo GH; Ramalho R; Sbaraini M; Leivas G; Martins AF; Schaan BD
    Diabetologia; 2021 Jan; 64(1):26-41. PubMed ID: 33047170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics, prebiotics, synbiotics and insulin sensitivity.
    Kim YA; Keogh JB; Clifton PM
    Nutr Res Rev; 2018 Jun; 31(1):35-51. PubMed ID: 29037268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of probiotics, prebiotics, and synbiotics in non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Rong L; Ch'ng D; Jia P; Tsoi KKF; Wong SH; Sung JJY
    J Gastroenterol Hepatol; 2023 Oct; 38(10):1682-1694. PubMed ID: 37409560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The promising role of probiotics/prebiotics/synbiotics in energy metabolism biomarkers in patients with NAFLD: A systematic review and meta-analysis.
    Li S; Liu J; Wang Z; Duan F; Jia Z; Chen X; Li S
    Front Public Health; 2022; 10():862266. PubMed ID: 35958869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
    Cho MS; Kim SY; Suk KT; Kim BY
    J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
    Sharpton SR; Maraj B; Harding-Theobald E; Vittinghoff E; Terrault NA
    Am J Clin Nutr; 2019 Jul; 110(1):139-149. PubMed ID: 31124558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Probiotics, Prebiotics and Synbiotics in Non-Alcoholic Fat Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review.
    Carpi RZ; Barbalho SM; Sloan KP; Laurindo LF; Gonzaga HF; Grippa PC; Zutin TLM; Girio RJS; Repetti CSF; Detregiachi CRP; Bueno PCS; Mazuqueli Pereira ESB; Goulart RA; Haber JFDS
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials.
    Sáez-Lara MJ; Robles-Sanchez C; Ruiz-Ojeda FJ; Plaza-Diaz J; Gil A
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of microbiome-modulating probiotics, prebiotics and synbiotics on glucose homeostasis in type 2 diabetes: A systematic review, meta-analysis, and meta-regression of clinical trials.
    Paul P; Kaul R; Harfouche M; Arabi M; Al-Najjar Y; Sarkar A; Saliba R; Chaari A
    Pharmacol Res; 2022 Nov; 185():106520. PubMed ID: 36272640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of probiotics, prebiotics and synbiotics on anthropometric, cardiometabolic and inflammatory markers: An umbrella review of meta-analyses.
    Teo YQJ; Chong B; Soong RY; Yong CL; Chew NW; Chew HSJ
    Clin Nutr; 2024 Jun; 43(6):1563-1583. PubMed ID: 38754308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease.
    Koopman N; Molinaro A; Nieuwdorp M; Holleboom AG
    Aliment Pharmacol Ther; 2019 Sep; 50(6):628-639. PubMed ID: 31373710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Probiotics/Synbiotics on Glucose and Lipid Metabolism in Women with Gestational Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.
    Mu J; Guo X; Zhou Y; Cao G
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics, prebiotics, and synbiotics supplementation in prediabetes: protocol for a systematic review and meta-analysis.
    Du X; Xie C; Shi L; Gao H; Yang C; Liu Q
    Medicine (Baltimore); 2020 Mar; 99(13):e19708. PubMed ID: 32221098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics and synbiotics supplementation improve glycemic control parameters in subjects with prediabetes and type 2 diabetes mellitus: A GRADE-assessed systematic review, meta-analysis, and meta-regression of randomized clinical trials.
    Naseri K; Saadati S; Ashtary-Larky D; Asbaghi O; Ghaemi F; Pashayee-Khamene F; Yari Z; de Courten B
    Pharmacol Res; 2022 Oct; 184():106399. PubMed ID: 35987483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis.
    Kanchanasurakit S; Kositamongkol C; Lanoi K; Nunta M; Saetuan T; Chaiyakunapruk N; Saokaew S; Phisalprapa P
    Front Nutr; 2022; 9():880014. PubMed ID: 35669067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.